Tandem Diabetes Care Inc
TNDM· Nasdaq
Released Jul 30, 2018, after the close
10-Q filed Jul 30, 2018, 30 days after period end · 0001564590-18-017895
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $34.13M | $21.33M | $22.99M | $15.71M |
| Net Income | -$59.36M | -$21.80M | -$18.33M | -$19.53M |
| EPS Diluted |
Tandem Diabetes Care Inc · CIK 1438133 · Engraved from SEC EDGAR
| -$1.17 |
| -$4.36 |
| -$6.00 |
| -$0.65 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.